137 related articles for article (PubMed ID: 12297606)
1. Emotional distress during interferon-alpha-2B and ribavirin treatment of chronic hepatitis C.
Fontana RJ; Schwartz SM; Gebremariam A; Lok AS; Moyer CA
Psychosomatics; 2002; 43(5):378-85. PubMed ID: 12297606
[TBL] [Abstract][Full Text] [Related]
2. Treatment-emergent depression and anxiety between peginterferon alpha-2a versus alpha-2b plus ribavirin for chronic hepatitis C.
Wang LJ; Chen SW; Chen CK; Yen CL; Chang JJ; Lee TS; Liu CJ; Chen LW; Chien RN
BMC Psychiatry; 2016 Nov; 16(1):424. PubMed ID: 27884134
[TBL] [Abstract][Full Text] [Related]
3. A prospective study of neuropsychiatric symptoms associated with interferon-alpha-2b and ribavirin therapy for patients with chronic hepatitis C.
Dieperink E; Ho SB; Thuras P; Willenbring ML
Psychosomatics; 2003; 44(2):104-12. PubMed ID: 12618532
[TBL] [Abstract][Full Text] [Related]
4. [Depressive symptoms during treatment with interferon alpha for HCV infection--preliminary report].
Małyszczak K; Inglot M; Pawłowski T; Czarnecki M; Rymer W; Andrzej K
Psychiatr Pol; 2006; 40(4):799-808. PubMed ID: 17068951
[TBL] [Abstract][Full Text] [Related]
5. Psychiatric side effects of pegylated interferon alfa-2b as compared to conventional interferon alfa-2b in patients with chronic hepatitis C.
Kraus MR; Schäfer A; Csef H; Scheurlen M
World J Gastroenterol; 2005 Mar; 11(12):1769-74. PubMed ID: 15793861
[TBL] [Abstract][Full Text] [Related]
6. Adverse cutaneous reactions to interferon alfa-2b plus ribavirin therapy in patients with chronic hepatitis C virus.
Manjón-Haces JA; Vázquez-López F; Gómez-Díez S; Hidalgo-García A; Pérez-Alvarez R; Soler-Sánchez T; Pérez-Oliva N
Acta Derm Venereol; 2001; 81(3):223. PubMed ID: 11558891
[No Abstract] [Full Text] [Related]
7. Role of baseline depressive symptoms in the development of depressive episode in patients receiving antiviral therapy for hepatitis C infection.
Mahajan S; Avasthi A; Grover S; Chawla YK
J Psychosom Res; 2014 Aug; 77(2):109-15. PubMed ID: 25077851
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of long-term efficacy of interferon alpha-2b and ribavirin in combination in naive patients with chronic hepatitis C: an Italian multicenter experience. Ribavirin-Interferon in Chronic Hepatitis Italian Group Investigators.
Barbaro G; Di Lorenzo G; Soldini M; Giancaspro G; Pellicelli A; Grisorio B; Barbarini G
J Hepatol; 2000 Sep; 33(3):448-55. PubMed ID: 11020001
[TBL] [Abstract][Full Text] [Related]
9. Psychopathological symptoms during interferon-alpha and ribavirin treatment: effects on virologic response.
Maddock C; Landau S; Barry K; Maulayah P; Hotopf M; Cleare AJ; Norris S; Pariante CM
Mol Psychiatry; 2005 Apr; 10(4):332-3. PubMed ID: 15655564
[No Abstract] [Full Text] [Related]
10. Pegylated interferon alpha-2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients.
Callens S; Bottieau E; Michielsen P; Colebunders R
AIDS; 2004 Jan; 18(1):131. PubMed ID: 15090841
[No Abstract] [Full Text] [Related]
11. A multidisciplinary therapeutic approach for reducing the risk of psychiatric side effects in patients with chronic hepatitis C treated with pegylated interferon α and ribavirin.
Neri S; Bertino G; Petralia A; Giancarlo C; Rizzotto A; Calvagno GS; Mauceri B; Abate G; Boemi P; Di Pino A; Ignaccolo L; Vadalà G; Misseri M; Maiorca D; Mastrosimone G; Judica A; Palermo F
J Clin Gastroenterol; 2010 Oct; 44(9):e210-7. PubMed ID: 20838237
[TBL] [Abstract][Full Text] [Related]
12. Intracerebral hemorrhage in a patient receiving combination therapy of pegylated interferon alpha-2b and ribavirin for chronic hepatitis C.
Nishiofuku M; Tsujimoto T; Matsumura Y; Toyohara M; Yoshiji H; Yamao J; Fukui H; Yoshikawa M
Intern Med; 2006; 45(7):483-4. PubMed ID: 16679707
[No Abstract] [Full Text] [Related]
13. DEPRESSIVE EPISODE INCIDENCE IN PATIENTS WITH CHRONIC HEPATITIS C TREATED WITH PEGYLATED INTERFERON AND RIBAVIRIN.
Vabo IL; Ferreira LE; Pace FH
Arq Gastroenterol; 2016; 53(1):20-4. PubMed ID: 27281500
[TBL] [Abstract][Full Text] [Related]
14. Assessment of adverse reactions and pharmacokinetics of ribavirin in combination with interferon alpha-2b in patients with chronic hepatitis C.
Uchida M; Hamada A; Yamasaki M; Fujiyama S; Sasaki Y; Saito H
Drug Metab Pharmacokinet; 2004 Dec; 19(6):438-43. PubMed ID: 15681898
[TBL] [Abstract][Full Text] [Related]
15. Daily or three times a week interferon alfa-2b in combination with ribavirin or interferon alone for the treatment of patients with chronic hepatitis C.
de Lédinghen V; Trimoulet P; Winnock M; Foucher J; Bourlière M; Desmorat H; Canva V; Capron D; Lévy S; Mion F; Mannant PR; Chêne G; Fleury H; Couzigou P; Bernard PH;
J Hepatol; 2002 May; 36(5):672-80. PubMed ID: 11983451
[TBL] [Abstract][Full Text] [Related]
16. Daily or three times per week interferon alpha-2b in combination with ribavirin or interferon alone for the treatment of patients with chronic hepatitis C not responding to previous interferon alone.
de Lédinghen V; Trimoulet P; Winnock M; Bernard PH; Bourlière M; Portal I; Rémy AJ; Szostak N; Lévy S; Tran A; Abergel A; Chêne G; Fleury H; Couzigou P;
J Hepatol; 2002 Jun; 36(6):819-26. PubMed ID: 12044534
[TBL] [Abstract][Full Text] [Related]
17. The Effect of Combination Antiviral Therapy in the Treatment of Hepatitis C on the Occurrence of Depressive Disorder in Patients Treated for Hepatitis C in the Republic of Srpska.
Banjac V; Zivlak-Radulovic N; Miskovic M
Med Arch; 2016 Apr; 70(2):127-30. PubMed ID: 27147788
[TBL] [Abstract][Full Text] [Related]
18. Neurocognitive changes in patients with hepatitis C receiving interferon alfa-2b and ribavirin.
Kraus MR; Schäfer A; Wissmann S; Reimer P; Scheurlen M
Clin Pharmacol Ther; 2005 Jan; 77(1):90-100. PubMed ID: 15637534
[TBL] [Abstract][Full Text] [Related]
19. Acute ulcerative colitis during successful interferon/ribavirin treatment for chronic hepatitis.
Sprenger R; Sagmeister M; Offner F
Gut; 2005 Mar; 54(3):438-9; author reply 439. PubMed ID: 15710996
[No Abstract] [Full Text] [Related]
20. Comparison of two PEG-interferon alpha-2b doses (1.0 or 1.5 microg/kg) combined with ribavirin in interferon-naïve patients with chronic hepatitis C and up to moderate fibrosis.
Meyer-Wyss B; Rich P; Egger H; Helbling B; Müllhaupt B; Rammert C; Gonvers JJ; Oneta C; Criblez D; Rossi L; Borovicka J; Meyenberger C; Arn M; Renner EL;
J Viral Hepat; 2006 Jul; 13(7):457-65. PubMed ID: 16792539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
